Search results for: 'device contract manufacturing'

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

The manufacturing sector is highly vulnerable to unpredictable market dynamics. Sudden changes in demand lead to major supply chain disruptions, resource shortages, increased turnaround time, and, most importantly, losses incurred while incorporating these changes in production processes. A comprehensive and adaptable system that meets business nee...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

The Brazilian and Mexican mobile device management (MDM) market reached $45.8 million in revenue in 2015. The Latin American market is in a nascent phase compared to other regions such as North America and Europe, presenting opportunities for new entrants, investments, mergers and acquisitions (M&As), and for existing integrators to increase their ...

The high demand for satellite manufacturing is the direct result of the increase in the number of satellite launches and increase in number of planned constellations. This has resulted in Serial production of satellites. The overall growth in the satellite manufacturing market has spurred the demand for satellite subsystem and component manufactur...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

Additive manufacturing (AM) technologies have been undergoing considerable technological growth in recent years. The technology is playing an instrumental role in transforming several industries, such as automotive, aerospace, medical, and oil and gas. Due to the advantages of AM technology, it is now witnessing immense traction from the constructi...

Automotive manufacturing is a complex and ever-evolving industry shaped by technological advancements, economic conditions, and consumer preferences. As the demand for automobiles grew, automotive manufacturing has evolved from being highly reliant on manual labor to adopting new technologies and mass production techniques. The most important devel...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...